Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 792K
7: EX-4.8 Instrument Defining the Rights of Security Holders HTML 95K
2: EX-10.5 Material Contract HTML 55K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 32K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 27K
54: R1 Document and Entity Information HTML 78K
32: R2 Consolidated Balance Sheets (Unaudited) HTML 111K
39: R3 Consolidated Balance Sheets (Unaudited) HTML 47K
(Parenthetical)
83: R4 Consolidated Statements Of Operations And HTML 97K
Comprehensive Loss (Unaudited)
52: R5 Consolidated Statements of Stockholders' (Deficit) HTML 58K
Equity (Unaudited)
31: R6 Consolidated Statements Of Cash Flows (Unaudited) HTML 134K
38: R7 Description of Business and Basis of Presentation HTML 42K
81: R8 Summary of Significant Accounting Policies HTML 40K
55: R9 Revenue Recognition HTML 215K
48: R10 Stockholders' (Deficit) Equity HTML 300K
21: R11 Inventory HTML 46K
64: R12 Property, Plant, and Equipment HTML 67K
73: R13 Intangible Assets and Goodwill HTML 29K
47: R14 Accrued Liabilities HTML 117K
20: R15 Debt HTML 103K
63: R16 Leases HTML 74K
72: R17 Commitments and Contingencies HTML 34K
46: R18 Segment Information HTML 75K
22: R19 Concentrations HTML 114K
50: R20 Income Taxes HTML 31K
79: R21 Subsequent Events HTML 36K
34: R22 Summary of Significant Accounting Policies HTML 77K
(Policies)
24: R23 Revenue Recognition (Tables) HTML 296K
49: R24 Stockholders' (Deficit) Equity (Tables) HTML 304K
78: R25 Inventory (Tables) HTML 47K
33: R26 Property, Plant, and Equipment (Tables) HTML 66K
23: R27 Accrued Liabilities (Tables) HTML 118K
51: R28 Debt (Tables) HTML 79K
77: R29 Leases (Tables) HTML 75K
74: R30 Segment Information (Tables) HTML 76K
66: R31 Concentrations (Tables) HTML 166K
18: R32 Description of Business and Basis of Presentation HTML 69K
- Additional Information (Detail)
44: R33 Summary of Significant Accounting Policies - HTML 36K
Additional Information (Detail)
75: R34 Revenue Recognition - Additional Information HTML 38K
(Detail)
67: R35 Summary of Opening and Closing Balances of HTML 36K
Contract Liabilities (Detail)
19: R36 Summary of Disaggregation of Revenues Related to HTML 32K
Geographic Areas (Detail)
45: R37 Summary of Revenues Disaggregated by Timing of HTML 33K
Goods and Services Transferred (Detail)
76: R38 Summary of Sales by End Market (Detail) HTML 33K
65: R39 Summary of Percentages of Sales by Product line HTML 40K
(Detail)
80: R40 Stockholders' (Deficit) Equity - Additional HTML 84K
Information (Detail)
56: R41 Classification of Compensation Expense Associated HTML 38K
with Share-Based Payments (Detail)
29: R42 Assumptions Used in Estimating Fair Value of Stock HTML 34K
Options Granted (Detail)
40: R43 Summary of Option Activity (Detail) HTML 65K
82: R44 Summary of Unvested Stock Option Activity (Detail) HTML 47K
57: R45 Cash Proceeds Along with Fair Value Disclosures HTML 33K
Related to Grants, Exercises and Vested Options
(Detail)
30: R46 Summary of Unvested Restricted Stock Units HTML 50K
(Detail)
41: R47 Summary of Warrant Activity (Detail) HTML 43K
84: R48 Components of Inventory (Detail) HTML 35K
53: R49 Inventory - Additional Information (Detail) HTML 28K
61: R50 Summary of Property, Plant, and Equipment (Detail) HTML 49K
70: R51 Property, Plant, and Equipment - Additional HTML 28K
Information (Detail)
43: R52 Intangible Assets and Goodwill - Additional HTML 34K
Information (Detail)
17: R53 Components of Accrued Liabilities (Detail) HTML 52K
60: R54 Changes in Initial Product Warranty Accrual and HTML 41K
Expenses Under Initial and Extended Warranties
(Detail)
69: R55 Accrued Liabilities - Additional Information HTML 33K
(Detail)
42: R56 Debt - Summary of Principal Outstanding and HTML 33K
Unamortized Discount (Detail)
16: R57 Debt - Additional Information (Detail) HTML 209K
62: R58 Debt - Summary of Future Minimum Principal and HTML 49K
Interest Payments (Detail)
68: R59 Leases - Additional Information (Detail) HTML 59K
37: R60 Leases - Information related to Right-of-use HTML 34K
Assets and Liabilities (Detail)
27: R61 Leases - Schedule of Maturities of Lease HTML 39K
Liabilities (Detail)
59: R62 Leases - Future Minimum Rental Commitments Under HTML 35K
Lease Agreements (Detail)
86: R63 Commitments and Contingencies - Additional HTML 56K
Information (Detail)
36: R64 Segment Information - Additional Information HTML 39K
(Detail)
26: R65 Summary of Net Revenue by Geographic Location HTML 32K
(Detail)
58: R66 Summary of Property, Plant and Equipment by HTML 33K
Geographic Location (Detail)
85: R67 Concentrations - Summary of Net Revenue from HTML 51K
Various Products (Detail)
35: R68 Concentrations - Additional Information (Detail) HTML 41K
28: R69 Income Taxes - Additional Information (Detail) HTML 37K
15: R70 Subsequent Events - Additional Information HTML 88K
(Detail)
14: XML IDEA XML File -- Filing Summary XML 153K
71: EXCEL IDEA Workbook of Financial Reports XLSX 91K
8: EX-101.INS XBRL Instance -- biol-20190930 XML 2.79M
10: EX-101.CAL XBRL Calculations -- biol-20190930_cal XML 170K
11: EX-101.DEF XBRL Definitions -- biol-20190930_def XML 583K
12: EX-101.LAB XBRL Labels -- biol-20190930_lab XML 1.39M
13: EX-101.PRE XBRL Presentations -- biol-20190930_pre XML 1.06M
9: EX-101.SCH XBRL Schema -- biol-20190930 XSD 215K
25: ZIP XBRL Zipped Folder -- 0001564590-19-042402-xbrl Zip 178K
‘EXCEL’ — IDEA Workbook of Financial Reports
This is an IDEA Workbook.
11 Subsequent Filings that Reference this Filing
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent
1/03/23 Biolase, Inc. S-1/A 6:1M Donnelley … Solutions/FA
12/12/22 Biolase, Inc. S-1/A 7:1.1M Donnelley … Solutions/FA
11/22/22 Biolase, Inc. S-1 3:655K Donnelley … Solutions/FA
3/17/22 Biolase, Inc. 10-K 12/31/21 88:18M Donnelley … Solutions/FA
11/10/21 Biolase, Inc. 10-Q 9/30/21 84:13M Donnelley … Solutions/FA
8/13/21 Biolase, Inc. 10-Q 6/30/21 80:12M Donnelley … Solutions/FA
5/13/21 Biolase, Inc. 10-Q 3/31/21 81:9.4M Donnelley … Solutions/FA
3/31/21 Biolase, Inc. 10-K 12/31/20 88:15M ActiveDisclosure/FA
12/08/20 Biolase, Inc. S-1/A 3:585K Donnelley … Solutions/FA
11/13/20 Biolase, Inc. 10-Q 9/30/20 81:11M ActiveDisclosure/FA
8/14/20 Biolase, Inc. 10-Q 6/30/20 89:12M ActiveDisclosure/FA
|
↑Top
Filing Submission 0001564590-19-042402 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Thu., Apr. 25, 1:47:43.1am ET